Skip to Content

Lipegfilgrastim

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L03AA14

CAS registry number (Chemical Abstracts Service)

1117844-87-7

Chemical Formula

C864-H1369-N225-O258-S9-[C2-H4-O]n

Molecular Weight

19433

Therapeutic Categories

Immunostimulant

Hematopoietic growth factor: Stimulation of thrombopoiesis

Chemical Name

Pegylated granulocyte colony stimulating factor (human short isoform); O³.¹³⁷-[{3,5-dideoxy-5-[(N-{[ω-methoxypoly(oxyethylene)]carbonyl}glycyl)amino]-D-glycero-α-D-galacto-non-2-ulopyranosylonic acid}-(2→6)-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl]-de (WHO)

Foreign Names

  • Lipegfilgrastimum (Latin)
  • Lipegfilgrastim (German)
  • Lipegfilgrastim (French)
  • Lipegfilgrastim (Spanish)

Generic Names

  • Lipegfilgrastim (OS: USAN)
  • UNII-4AWFON6QV3 (IS)
  • XM22 (IS)

Brand Names

  • Longuex
    Sicor Biotech, Croatia (Hrvatska)
  • Lonquex
    Ratiopharm, Finland; Teva, Belgium; Teva, Germany; Teva, Denmark; Teva, Spain; Teva, Latvia; Teva, Netherlands; Teva, Norway; Teva, Sweden; Teva, Slovakia; Teva Italia, Italy; Teva Pharmaceuticals, United Kingdom; UAB Norameda, Poland; UAB Sicor Biotech, Austria

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide